Efficacy and safety of sintilimab plus bevacizumab and CAPOX as first-line treatment for patients with RAS-mutant, microsatellite stable, metastatic colorectal cancer by Yanrong Wang, Ru Jia, Haiyan Si, Yue Ma, Mengjiao Fan, Nan Zhang, Fangfang Liu, Yue Shi, Yushan Jia, Yaoyue Zhang, Quanli Han, Zhikuan Wang, Guanghai Dai

Get full text